Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome

Hideki Muramatsu, Hirotoshi Sakaguchi, Takashi Taga, Ken Tabuchi, Souichi Adachi, Masami Inoue, Toshiyuki Kitoh, Aiko Suminoe, Hiromasa Yabe, Eichi Azuma, Yoko Shioda, Atsushi Ogawa, Akitoshi Kinoshita, Hisato Kigasawa, Yuko Osugi, Kazutoshi Koike, Keisei Kawa, Koji Kato, Yoshiko Atsuta, Kazuko Kudo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) has not been widely used in patients with acute myeloid leukemia (AML) and Down syndrome (DS) due to fear of transplantation-related toxicity. A retrospective analysis of the outcome of allogeneic HSCT was conducted in 15 patients with AML and DS. The five patients transplanted with the reduced intensity conditioning (4 in complete remission (CR) and 1 in non-CR) had a significantly better survival rate than 10 patients transplanted with a conventional conditioning (4 in CR and 6 in non-CR) (3-year EFS (95% confidence interval): 80.0% (20.4-96.9%) vs. 10.0% (0.6%-35.8%), P=0.039). Pediatr Blood Cancer 2014;61:925-927.

Original languageEnglish
Pages (from-to)925-927
Number of pages3
JournalPediatric Blood and Cancer
Volume61
Issue number5
DOIs
Publication statusPublished - May 2014
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome'. Together they form a unique fingerprint.

Cite this